Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 25.90
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
SHA:688739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 177.94 | 342.82 | 465.92 | 714.02 | 892.49 | 918.19 |
Depreciation & Amortization | 169.7 | 169.7 | 125.27 | 121.22 | 116.1 | 64.84 |
Other Amortization | 6.3 | 6.3 | 3.71 | 2.22 | 1.32 | 0.64 |
Loss (Gain) From Sale of Assets | -0.09 | -0.09 | -2.48 | -0.04 | -0.01 | -0.13 |
Asset Writedown & Restructuring Costs | 1.8 | 1.8 | 0.87 | 0.83 | 0.71 | 23.78 |
Loss (Gain) From Sale of Investments | 60.02 | 60.02 | 20.27 | -27.25 | -14.2 | -89.21 |
Provision & Write-off of Bad Debts | 8.66 | 8.66 | 12.77 | 15.08 | 16.44 | -6.26 |
Other Operating Activities | 77.93 | 33.21 | 55.43 | 7.98 | 8.11 | 4.29 |
Change in Accounts Receivable | -18.02 | -18.02 | 13.82 | -156.41 | -436.49 | -31.05 |
Change in Inventory | -73.27 | -73.27 | 0.42 | -104.11 | -109.74 | -31.42 |
Change in Accounts Payable | -27.59 | -27.59 | -11.84 | -17.55 | 45.15 | -0.18 |
Change in Other Net Operating Assets | 0.06 | 0.06 | 0.06 | 0.08 | 0.1 | -0.61 |
Operating Cash Flow | 380.8 | 500.96 | 677.01 | 546.49 | 506.38 | 859.55 |
Operating Cash Flow Growth | -27.57% | -26.00% | 23.88% | 7.92% | -41.09% | 18.74% |
Capital Expenditures | -354.46 | -362.48 | -551.99 | -511.61 | -508.35 | -188.2 |
Sale of Property, Plant & Equipment | 0.1 | 10.98 | 0.02 | 0.15 | 0.02 | 0.21 |
Cash Acquisitions | -0.06 | -0.06 | -0.06 | -0.08 | -0.09 | - |
Investment in Securities | 36.33 | 156.81 | -883.2 | 3,327 | -2,598 | -733.15 |
Other Investing Activities | 32.81 | 31.92 | 32.95 | 75.04 | 40.72 | 38.94 |
Investing Cash Flow | -285.28 | -162.83 | -1,402 | 2,890 | -3,066 | -882.2 |
Long-Term Debt Repaid | - | -5.85 | -6.38 | -5.41 | -5.63 | - |
Net Debt Issued (Repaid) | -5.85 | -5.85 | -6.38 | -5.41 | -5.63 | - |
Issuance of Common Stock | - | - | - | - | 4,371 | - |
Repurchase of Common Stock | -50 | -50 | -99.99 | - | - | - |
Common Dividends Paid | -329.24 | -329.38 | -416.32 | -416.3 | - | -224.88 |
Dividends Paid | -329.24 | -329.38 | -416.32 | -416.3 | - | -224.88 |
Other Financing Activities | 39.16 | - | - | - | -18.95 | -11 |
Financing Cash Flow | -345.93 | -385.23 | -522.69 | -421.7 | 4,347 | -235.88 |
Foreign Exchange Rate Adjustments | 1.15 | 0.55 | 2.29 | 1.58 | -0.36 | -1.05 |
Net Cash Flow | -249.26 | -46.55 | -1,246 | 3,017 | 1,787 | -259.58 |
Free Cash Flow | 26.34 | 138.48 | 125.02 | 34.89 | -1.97 | 671.35 |
Free Cash Flow Growth | -84.95% | 10.76% | 258.36% | - | - | 155.91% |
Free Cash Flow Margin | 1.79% | 8.26% | 7.14% | 1.92% | -0.09% | 33.64% |
Free Cash Flow Per Share | 0.06 | 0.34 | 0.30 | 0.08 | -0.01 | 1.79 |
Cash Income Tax Paid | 131.72 | 177.45 | 182.09 | 211.18 | 198.48 | 227.65 |
Levered Free Cash Flow | -105.81 | 52.09 | 46.39 | -182.35 | -228.08 | 461.99 |
Unlevered Free Cash Flow | -104.93 | 53.08 | 47.28 | -181.53 | -227.12 | 461.99 |
Change in Working Capital | -121.46 | -121.46 | -4.75 | -287.57 | -514.57 | -56.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.